MREO

Mereo BioPharma
MREO

Overview Fund Activity

80 hedge funds and large institutions have $277M invested in Mereo BioPharma in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 11 closing their positions.

Holders
80
Holders Change
+16
Holders Change %
+25%
% of All Funds
1.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
28
Increased
24
Reduced
12
Closed
11
Calls
$2.63M
Puts
$1M
Net Calls
+$1.63M
Net Calls Change
-$481K

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$30.8M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$16.9M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$5.34M
4
Morgan Stanley
4
Morgan Stanley
New York
$4.56M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$3.27M

Top Sellers

1
SCM
1
Soleus Capital Management
Connecticut
$8.64M
2
SCM
2
Suvretta Capital Management
New York
$12.1M
3
TC
3
Tejara Capital
United Kingdom
$8.15M
4
Aberdeen Group
4
Aberdeen Group
United Kingdom
$2.7M
5
DCM
5
DAFNA Capital Management
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
RCMNY
1
Rubric Capital Management (New York)
New York
$44.7M 13,552,997 – –
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$30.8M 9,328,739 +6,678,739 +252%
MP
3
Mangrove Partners
Connecticut
$28.9M 8,752,893 – –
RSCM
4
Rock Springs Capital Management
Maryland
$26.9M 8,142,109 +158,258 +2%
6CM
5
683 Capital Management
New York
$19M 5,750,000 -450,000 -7%
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$16.9M 5,120,573 +5,120,573 New
Alkeon Capital Management
7
Alkeon Capital Management
New York
$14M 4,238,100 – –
SCM
8
Suvretta Capital Management
New York
$12.1M 3,653,494 -3,717,344 -50%
CC
9
Clearline Capital
New York
$11M 3,326,718 – –
SCM
10
Soleus Capital Management
Connecticut
$8.64M 2,616,953 -7,160,466 -73%
TC
11
Tejara Capital
United Kingdom
$8.15M 2,470,184 -1,242,945 -33%
Goldman Sachs
12
Goldman Sachs
New York
$7.4M 2,243,814 +220,142 +11%
Millennium Management
13
Millennium Management
New York
$7.19M 2,179,135 +768,818 +55%
Renaissance Technologies
14
Renaissance Technologies
New York
$5.52M 1,672,309 -125,700 -7%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$5.34M 1,619,627 +1,443,999 +822%
Morgan Stanley
16
Morgan Stanley
New York
$4.56M 1,382,689 +1,230,359 +808%
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$3.27M 991,971 +991,971 New
IHAM
18
Integral Health Asset Management
New York
$3.14M 950,000 +950,000 New
Aberdeen Group
19
Aberdeen Group
United Kingdom
$2.7M 817,309 -733,773 -47%
NIM
20
NEOS Investment Management
Connecticut
$2.06M 623,430 +271,525 +77%
Verition Fund Management
21
Verition Fund Management
Connecticut
$1.6M 485,436 +485,436 New
AGP
22
Artia Global Partners
Florida
$1.39M 421,359 +421,359 New
MAM
23
Monaco Asset Management
Monaco
$1.34M 405,000 -271,494 -40%
ACP
24
Acuta Capital Partners
California
$1.31M 397,884 +397,884 New
Two Sigma Investments
25
Two Sigma Investments
New York
$1.16M 351,729 +40,669 +13%
1
2 3 4